Finance

Lists
Why is SGMT down 5,45%?
Dive Deeper
SGMT:NASDAQ
Sagimet Biosciences Inc
7,54 US$
-5,45%
(-0,43) 1D
7,53 US$
-0,20% (-0,015)
After hours
Closed: 14 ოქტ, 16:00:01 GMT-4  ·   USD
All symbols
SymbolPriceChange% Change
Generating top insights for SGMT...
Open
7,78 US$
High
8,00 US$
Low
7,51 US$
Mkt. cap
532,17 მლნ.
Avg. vol.
1,37 მლნ.
Volume
1,98 მლნ.
52-wk high
11,45 US$
52-wk low
4,50 US$
EPS
-1,28 US$
Beta
3,46
Shares outstanding
70,34 მლნ.
No. of employees
16
Open
7,78 US$
High
8,00 US$
Low
7,51 US$
Mkt. cap
532,17 მლნ.
Avg. vol.
1,37 მლნ.
Volume
1,98 მლნ.
52-wk high
11,45 US$
52-wk low
4,50 US$
EPS
-1,28 US$
Beta
3,46
Shares outstanding
70,34 მლნ.
No. of employees
16
News stories
From web sources and news partners
Quiver Quantitative
Quiver Quantitative
·
1 დღის წინ
$SGMT stock is down 9% today. Here's what we see in our data.
About Sagimet Biosciences Inc
CEO-
Employees16
Founded2006
HeadquartersSan Mateo, კალიფორნია, ამერიკის შეერთებული შტატები
Sector-
Analyst ratings
Based on 12 analysts giving stock ratings to SGMT in the past 3 months
Strong buy
Buy
11
Hold
0
Sell
1
12-month forecast
Based on 12 Wall Street analysts offering 12 month price targets for SGMT in the last 3 months.
Highest
Current 7,54 US$
56,00 US$ (+642,21%)
Average
28,46 US$ (+277,20%)
Lowest
7,00 US$ (-7,22%)
Analyst
Recommendation
Action
Price target
Projected
Date
Brandon Folkes
H.C. Wainwright
Buy
Reiterated
29,00 US$
+284,4%
10/05/2026
Seamus Fernandez
Guggenheim
Buy
Reiterated
26,00 US$
+244,6%
10/01/2026
Thomas Smith
Leerink Partners
Buy
Reiterated
-
-
10/01/2026
Andrea Newkirk
Goldman Sachs
Sell
Maintained
7,00 US$
-7,2%
09/30/2026
Jay Olson
Oppenheimer
Buy
Maintained
38,00 US$
+403,6%
10/01/2026
Edward Nash
Canaccord Genuity
Buy
Reiterated
56,00 US$
+642,2%
10/01/2026
Yanni Souroutzidis
Cantor Fitzgerald
Buy
Maintained
25,10 US$
+232,7%
10/01/2026
Yun Zhong
Wedbush
Buy
Maintained
28,00 US$
+271,1%
10/01/2026
Jonathan Wolleben
Citizens JMP
Buy
Maintained
27,00 US$
+257,9%
10/01/2026
Kaveri Pohlman
Clear Street
Buy
Maintained
28,00 US$
+271,1%
09/30/2026
Debanjana Chatterjee
JonesTrading
Buy
Reiterated
31,00 US$
+310,9%
09/27/2026
Eliana Merle
Barclays
Buy
Upgraded
18,00 US$
+138,6%
09/09/2026
Ritu Baral
TD Cowen
Buy
Maintained
21,00 US$
+178,3%
05/12/2026
Unknown Analyst
Rodman & Renshaw
Buy
Initiated
28,00 US$
+271,1%
03/26/2026
Seema Sheoran
Rodman & Renshaw
Buy
Initiated
28,00 US$
+271,1%
03/26/2026
Previous reportsAll values in USD
Loading Previous Earnings...
Revenue
Net income
All values in USD
სექ. 2025
დეკ. 2025
მარ. 2026
ივნ. 2026
Revenue
-
-
-
-
Cost of goods sold
-
-
-
-
Cost of revenue
-
-
-
-
Research and development expenses
9,73 მლნ.
6,73 მლნ.
7,00 მლნ.
11,54 მლნ.
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
4,60 მლნ.
4,03 მლნ.
4,72 მლნ.
4,28 მლნ.
Operating expense
14,33 მლნ.
10,76 მლნ.
11,71 მლნ.
15,82 მლნ.
Total operating expenses
14,33 მლნ.
10,76 მლნ.
11,71 მლნ.
15,82 მლნ.
Operating income
-14,33 მლნ.
-10,76 მლნ.
-11,71 მლნ.
-15,82 მლნ.
Other non operating income
-
-
-
-
EBT including unusual items
-12,91 მლნ.
-9,57 მლნ.
-10,65 მლნ.
-13,95 მლნ.
EBT excluding unusual items
-12,91 მლნ.
-9,57 მლნ.
-10,65 მლნ.
-13,95 მლნ.
Income tax expense
-
-
-
-
Effective tax rate
-
-
-
-
Other operating expenses
-
-
-
-
Net income
-12,91 მლნ.
-9,57 მლნ.
-10,65 მლნ.
-13,95 მლნ.
Net profit margin
-
-
-
-
Earnings per share
-0,40
-0,29
-0,33
-0,26
Interest and investment income
1,43 მლნ.
1,20 მლნ.
1,06 მლნ.
1,86 მლნ.
Interest expense
-
-
-
-
Net interest expenses
1,43 მლნ.
1,20 მლნ.
1,06 მლნ.
1,86 მლნ.
Depreciation and amortization charges
-
-
-
-
EBITDA
-
-
-
-
Gain or loss from assets sale
-
-
-
-
Insider transactions
Insider transactions data is drawn from third-party sources. Learn more
Insider
Position
Type
Date
Shares
Amount
Page 1
AI content may include mistakes. Learn more
Google აპები